Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
ABT - Abbott Laboratories
Market Cap 188.88B P/E 33.02 EPS this Y -2.50% Ern Qtrly Grth -7.10%
Income 5.61B Forward P/E 23.51 EPS next Y 10.90% 50D Avg Chg 2.00%
Sales 40.33B PEG 3.26 EPS past 5Y 9.85% 200D Avg Chg 3.00%
Dividend 2.00% Price/Book 5.10 EPS next 5Y 7.57% 52W High Chg -6.00%
Recommedations 2.00 Quick Ratio - Shares Outstanding 1.74B 52W Low Chg 16.00%
Insider Own 0.54% ROA - Shares Float 1.72B Beta 0.74
Inst Own 77.03% ROE - Shares Shorted/Prior 12.94M/15.72M Price 108.62
Gross Margin 55.28% Profit Margin 13.96% Avg. Volume 4,711,008 Target Price 118.35
Oper. Margin 14.06% Earnings Date Jul 18 Volume 4,699,325 Change -1.73%
Healthcare | Medical Devices | United States
About Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Abbott Laboratories News
04/23/24 It's Draft Day: Damar Hamlin Helps Build the Abbott HeartMates Team
04/22/24 Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know
04/20/24 We Think Some Shareholders May Hesitate To Increase Abbott Laboratories' (NYSE:ABT) CEO Compensation
04/19/24 Should You Expect Accelerating Earnings Growth for Abbott Laboratories (ABT)?
04/19/24 Results: Abbott Laboratories Beat Earnings Expectations And Analysts Now Have New Forecasts
04/18/24 Abbott Laboratories (NYSE:ABT) Q1 2024 Earnings Call Transcript
04/18/24 Abbott Laboratories First Quarter 2024 Earnings: EPS Beats Expectations
04/18/24 Abbott Laboratories (ABT) Q1 2024 Earnings Call Transcript Highlights: Surpassing Expectations ...
04/17/24 Q1 2024 Abbott Laboratories Earnings Call
04/17/24 Abbott Undercuts Its 200-Day Line And A Flat Base Despite Its 'Solid' Quarterly Report
04/17/24 U.S. Stocks Slide On Tech Weakness
04/17/24 Abbott Laboratories (ABT) Q1 2024 Earnings Call Transcript
04/17/24 Abbott Labs Q1 Revenue Jumps On Strong Medical Devices Sales, Company Boosts Annual Guidance
04/17/24 Abbott (ABT) Q1 Earnings Beat Estimates, Margins Contract
04/17/24 Abbott Labs posts Q1 earnings beat
04/17/24 Abbott Labs Stock Is Slipping After Earnings Beat. Here’s Why.
04/17/24 Abbott (ABT) Reports Q1 Earnings: What Key Metrics Have to Say
04/17/24 Abbott Laboratories (ABT) Q1 Earnings: Surpasses EPS Estimates and Raises Full-Year Guidance
04/17/24 Abbott (ABT) Tops Q1 Earnings and Revenue Estimates
04/17/24 UPDATE 4-Abbott's device sales drive profit beat, but shares fall as forecast disappoints
ABT Chatroom

User Image TalkMarkets Posted - 4 hours ago

Intelligent Bio Solutions’ Fingerprint Drug Screening Technology Poised For Massive Growth $INBS Also $ABT $DGX $LH $OSUR https://talkmarkets.com/content/stocks--equities/intelligent-bio-solutions-fingerprint-drug-screening-technology-poised-for-massive-growth?post=442811

User Image TalkMarkets Posted - 4 hours ago

Intelligent Bio Solutions’ Fingerprint Drug Screening Technology Poised For Massive Growth $INBS Also $ABT $DGX $LH $OSUR https://talkmarkets.com/content/stocks--equities/intelligent-bio-solutions-fingerprint-drug-screening-technology-poised-for-massive-growth?post=442811

User Image iBoughtTheWrongTicker Posted - 1 day ago

$ABT strong ass MFing recovery

User Image StockFreedom Posted - 1 day ago

$ABT added this AM, now lets go up and close that GAP!

User Image DefenseMania Posted - 1 day ago

$LLY $ABT $MDT $NVDA

User Image StockFreedom Posted - 1 day ago

$ABT adding here as it bounces off support!

User Image minter66 Posted - 1 day ago

$ABT I hate this

User Image Stock_Titan Posted - 2 days ago

$ABT It’s Draft Day: Damar Hamlin Helps Build the Abbott HeartMates Team https://www.stocktitan.net/news/ABT/it-s-draft-day-damar-hamlin-helps-build-the-abbott-heart-mates-t7pzo6m4ygzi.html

User Image DefenseMania Posted - 2 days ago

$ABT $BMY $ AUPH

User Image Xeious Posted - 2 days ago

$ABT looks like sellers are playing with this one… not enough volume to close their positions

User Image reev Posted - 2 days ago

$ABT what is going on with this stock? Better makes up its mind so we can decide what position to take.

User Image minter66 Posted - 3 days ago

$ABT what was with the AH dip?

User Image reev Posted - 3 days ago

$ABT This either going over $110 or below $100, but it’s hard to say, not a lot of volume, we should know by Wednesday.

User Image reev Posted - 3 days ago

@Stocksrunner Yea Barclays cuts $ABT price target by $1, they was a lot of effort on their end.

User Image Stocksrunner Posted - 3 days ago

💼 Today's Target Price Updates: $CMA Truist Securities lowers price target post Q1 beat, adjusting EPS estimates. $ABT Barclays cuts stock target but maintains Overweight rating. $PFS target raised on stable outlook. $BYND target reduced, maintaining underperform rating due to cautious stance. $FIVN receive price target cut despite buy rating, reflecting cautious outlook. https://stocksrunner.com/target

User Image reev Posted - 3 days ago

$ABT literally blank board, what’s going on? No one interested in Thai stock or options, amazed.

User Image StockFreedom Posted - 6 days ago

$OPK Bag holders here may want to look at $ABT. Just saying....

User Image aiCAT Posted - 6 days ago

$ABT testing RL again

User Image aiCAT Posted - 6 days ago

$ABT range

User Image aiCAT Posted - 6 days ago

$ABT Bulls testing the middle of the channel ~106.50 going higher if this holds

User Image reev Posted - 6 days ago

$ABT over 8000 call options at $108, that is what’s stopping this here.

User Image StockFreedom Posted - 6 days ago

$ABT should at the very least go up and cover that $114-$118 GAP. No GAPs up please!

User Image StockFreedom Posted - 6 days ago

@Barnman09 suggest you look into $ABT.

User Image drtadawul Posted - 6 days ago

$ABT

User Image Boby2023 Posted - 6 days ago

$ABT i think shorts cover at 108.00 break.

User Image Boby2023 Posted - 6 days ago

$ABT way up next week. Also. $LVS.

User Image DonCorleone77 Posted - 1 week ago

$ABT Abbott Q1 strong but still in penalty box on litigation overhang, says Bernstein Bernstein analyst Lee Hambright keeps an Outperform rating and $133 price target on Abbott after its Q1 earnings. The quarter was strong and the company issued a "rare" post-Q1 guidance upgrade while also calling for a 70bps mross margin improvement in 2024, the analyst tells investors in a research note. The firm also believes that the stock is undervalued at current levels and expects itsLibre 3 ramp to continue to be an important growth driver, though the infant formula NEC litigation could keep Abbott in a holding pattern at least until cases get through court this summer.

User Image ST4Life Posted - 1 week ago

$ABT

User Image TheFinancialBull Posted - 1 week ago

$ABT 160%

User Image reev Posted - 1 week ago

$ABT if this really opens above $106 tomororw, today was a pretty good trap to kill options.

Analyst Ratings
Barclays Overweight Apr 22, 24
RBC Capital Outperform Apr 18, 24
Evercore ISI Group Outperform Apr 4, 24
Citigroup Buy Apr 3, 24
RBC Capital Outperform Feb 14, 24
Barclays Overweight Jan 26, 24
Citigroup Buy Jan 25, 24
RBC Capital Outperform Jan 25, 24
Raymond James Outperform Jan 25, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Wainer Andrea F EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Jan 29 Sell 112.5 42,500 4,781,250 65,027 01/31/24
Wainer Andrea F EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Jan 29 Option 52.17 42,500 2,217,225 82,527 01/31/24
Wainer Andrea F EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Dec 14 Sell 108 15,000 1,620,000 65,027 12/18/23
Wainer Andrea F EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Dec 14 Option 44.4 15,000 666,000 80,027 12/18/23
Wainer Andrea F EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Aug 08 Sell 105.95 10,400 1,101,880 65,027 08/10/23
Wainer Andrea F EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Aug 08 Option 38.4 5,000 192,000 75,427 08/10/23
STARKS DANIEL J Director Director Jul 27 Sell 113.72 50,000 5,686,000 6,775,316 07/28/23
Wainer Andrea F EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT May 02 Sell 110.56 8,226 909,467 70,427 05/03/23
Wainer Andrea F EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT May 02 Option 47 8,226 386,622 78,653 05/03/23
STARKS DANIEL J Director Director Apr 28 Sell 111.36 50,000 5,568,000 6,825,316 05/02/23
WOODGRIFT RANDEL WILLIAM SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Feb 28 Sell 100.7 1,032 103,922 52,203 03/02/23
Morrone Louis H. SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Feb 28 Sell 100.7 1,092 109,964 53,656 03/02/23
Moreland Mary K EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Feb 28 Sell 100.77 717 72,252 87,224 03/02/23
MANNING JOSEPH J EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Feb 28 Sell 100.7 1,339 134,837 62,323 03/02/23
Ginascol John F EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Feb 28 Sell 100.7 943 94,960 118,380 03/02/23
Funck, Jr. Robert E. EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Feb 28 Sell 100.7 1,264 127,285 218,237 03/02/23
Earnhardt Lisa D EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Feb 28 Sell 100.7 943 94,960 75,437 03/02/23
DALE MICHAEL D SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Feb 28 Sell 100.7 1,209 121,746 45,133 03/02/23
ALLEN HUBERT L EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Feb 28 Sell 100.7 1,069 107,648 175,959 03/02/23
Ahlberg Gregory A SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Feb 28 Sell 100.7 1,317 132,622 38,420 03/02/23
Karam Sammy SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Dec 29 Sell 108.75 4,200 456,750 26,462 01/03/23
Ginascol John F EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Dec 13 Sell 112.32 11,000 1,235,520 111,912 12/15/22
STARKS DANIEL J Director Director Oct 27 Sell 97.72 50,000 4,886,000 6,873,500 10/31/22
MANNING JOSEPH J EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Sep 08 Option 44.4 23,008 1,021,555 76,253 09/09/22
MANNING JOSEPH J EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Sep 08 Sell 107 23,008 2,461,856 53,245 09/09/22
Ford Robert B CHAIRMAN AND CEO CHAIRMAN AND CEO Aug 25 Option 40.13 102,425 4,110,315 244,496 08/26/22
Ford Robert B CHAIRMAN AND CEO CHAIRMAN AND CEO Aug 25 Sell 105.1 102,425 10,764,868 142,071 08/26/22
MANNING JOSEPH J EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Aug 25 Option 44.4 23,008 1,021,555 80,143 08/26/22
MANNING JOSEPH J EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Aug 25 Sell 105.12 26,898 2,827,518 53,245 08/26/22
STARKS DANIEL J Director Director Jul 26 Sell 109.19 50,000 5,459,500 6,923,500 07/28/22
Mateus Fernando SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Jul 26 Sell 109.0529 2,457 267,943 14,503 07/27/22
Tyler Julie L. SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Jul 25 Sell 109.09 253 27,600 33,868 07/27/22
WOODGRIFT RANDEL WILLIAM SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT May 04 Option 44.4 24,000 1,065,600 71,854 05/05/22
WOODGRIFT RANDEL WILLIAM SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT May 04 Sell 113 24,000 2,712,000 47,854 05/05/22
STARKS DANIEL J Director Director May 03 Sell 113.55 50,000 5,677,500 6,973,500 05/05/22
DALE MICHAEL D SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Mar 08 Sell 117.0003 4,000 468,001 41,780 03/10/22
WOODGRIFT RANDEL WILLIAM SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Feb 28 Sell 118.1 964 113,848 49,223 03/02/22
Watkin Jared SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Feb 28 Sell 118.1 1,038 122,588 66,545 03/02/22
Wainer Andrea F EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Feb 28 Sell 118.13 456 53,867 62,172 03/02/22
Salvadori Daniel Gesua Sive EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Feb 28 Sell 118.17 1,550 183,164 112,248 03/02/22
Morrone Louis H. SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Feb 28 Sell 118.16 656 77,513 47,278 03/02/22
MANNING JOSEPH J EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Feb 28 Sell 118.16 779 92,047 60,873 03/02/22
Ginascol John F EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Feb 28 Sell 118.16 365 43,128 124,680 03/02/22
Earnhardt Lisa D EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Feb 28 Sell 118.15 943 111,415 90,630 03/02/22
DALE MICHAEL D SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Feb 28 Sell 118.15 1,053 124,412 45,780 03/02/22
Calamari Christopher J. SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Feb 28 Sell 118.15 706 83,414 25,658 03/02/22
ALLEN HUBERT L EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Feb 28 Sell 118.17 1,450 171,346 167,095 03/02/22
Ahlberg Gregory A SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Feb 28 Sell 118.15 1,099 129,847 33,274 03/02/22
McKinstry Nancy Director Director Feb 24 Option 29.84 6,280 187,395 33,419 02/25/22
McKinstry Nancy Director Director Feb 24 Sell 116.43 1,614 187,918 31,805 02/25/22